Triphenylmethane derivatives have high in vitro and in vivo activity against the main causative agents of cutaneous leishmaniasis.
The current standard of care for cutaneous leishmaniasis (CL) is organic antimonial compounds, but the administration of these compounds is complicated by a low therapeutic - toxic index, as well as parenteral administration. Thus, there is an urgent need for the development of new and inexpensive t...
Saved in:
Main Authors: | Renata Celi Carvalho de Souza Pietra, Lucas Fonseca Rodrigues, Eliane Teixeira, Levi Fried, Benjamin Lefkove, Ana Rabello, Jack Arbiser, Lucas Antônio Miranda Ferreira, Ana Paula Fernandes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0051864&type=printable |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Occupationally Acquired American Cutaneous Leishmaniasis
by: Maria Edileuza Felinto de Brito, et al.
Published: (2012-01-01) -
Removal of Triphenylmethane Dyes by Bacterial Consortium
by: Jihane Cheriaa, et al.
Published: (2012-01-01) -
Microspatial Distributional Patterns of Vectors of Cutaneous Leishmaniasis in Pernambuco, Northeastern Brazil
by: Maria Rita Donalisio, et al.
Published: (2012-01-01) -
Mucosal leishmaniasis is associated with the Leishmania RNA virus and inappropriate cutaneous leishmaniasis treatment.
by: Fredy A Pazmiño, et al.
Published: (2025-01-01) -
Clinical Manifestations and Distribution of Cutaneous Leishmaniasis in Pakistan
by: Abaseen Khan Afghan, et al.
Published: (2011-01-01)